Travere Therapeutics, Inc.
TVTX
60 insider filings · Latest: Sep 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Sep 15 8:43 PM | ELIZABETH REED | Proposed Sale | 39,576 | $65.79 | $2.6M | — | View → |
| Sep 15, 2026 | Sep 15 8:42 PM | ERIC DUBE | Proposed Sale | 95,666 | $65.79 | $6.3M | — | View → |
| Sep 15, 2026 | Sep 15 8:41 PM | PETER HEERMA | Proposed Sale | 102,190 | $65.79 | $6.7M | — | View → |
| Sep 15, 2026 | Sep 15 8:35 PM | WILLIAM ROTE | Proposed Sale | 96,198 | $65.79 | $6.3M | — | View → |
| Sep 15, 2026 | Sep 15 8:24 PM | JULA INRIG | Proposed Sale | 44,674 | $65.79 | $2.9M | — | View → |
| Sep 10, 2026 | Sep 11 8:05 PM | Meckler Jeffrey ADirector | Sale | 20,000 | $67.31 | $1.3M | 91,500(D) | View → |
| Sep 10, 2026 | Sep 10 8:38 PM | JEFFREY MECKLER | Proposed Sale | 20,000 | $66.22 | $1.3M | — | View → |
| Sep 2, 2026 | Sep 3 8:05 PM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Sale | 642 | $66.37 | $42.6K | 118,016(D) | View → |
| Aug 18, 2026 | Aug 19 8:05 PM | LYONS GARY ADirector | Sale | 5,000 | $63.37 | $316.9K | 61,500(D) | View → |
| Aug 17, 2026 | Aug 19 8:05 PM | LYONS GARY ADirector | Sale | 5,000 | $63.20 | $316.0K | 61,500(D) | View → |
| Aug 18, 2026 | Aug 18 8:24 PM | GARY LYONS | Proposed Sale | 5,000 | $63.53 | $317.6K | — | View → |
| Aug 17, 2026 | Aug 17 8:31 PM | GARY A LYONS | Proposed Sale | 5,000 | $62.14 | $310.7K | — | View → |
| Jun 12, 2026 | Jun 16 8:46 PM | Timothy CoughlinDirector | Sale | 10,000 | $50.07 | $500.7K | 56,250(D) | View → |
| Jun 12, 2026 | Jun 16 8:42 PM | Roy D. BaynesDirector | Sale | 4,500 | $50.00 | $225.0K | 41,500(D) | View → |
| Jun 12, 2026 | Jun 12 8:05 PM | ROY BAYNES | Proposed Sale | 4,500 | $50.00 | $225.0K | — | View → |
| Jun 12, 2026 | Jun 12 4:20 PM | Coughlin Timothy | Proposed Sale | 10,000 | $50.04 | $500.4K | — | View → |
| May 15, 2026 | May 19 8:05 PM | Timothy CoughlinDirector | Sale | 3,250 | $43.49 | $141.3K | 52,250(D) | View → |
| May 15, 2026 | May 15 4:51 PM | Coughlin Timothy | Proposed Sale | 3,250 | $43.44 | $141.2K | — | View → |
| May 5, 2026 | May 7 12:00 AM | Roy D. BaynesDirector | Sale | 4,500 | $46.65 | $209.9K | 37,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Meckler Jeffrey ADirector | Sale | 8,000 | $45.00 | $360.0K | 87,500(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | May 4 8:27 PM | Roy D. BaynesDirector | Option Exercise | 9,750 | $6.82 | 9,750(D) | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | LYONS GARY ADirector | Option Exercise | 8,000 | $16.33 | 0(D) | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | Roy D. BaynesDirector | Option Exercise | 32,750 | $21.38 | 6,750(D) | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | Sandra CalvinSVP, CHIEF ACCOUNTING OFFICER | Option Exercise | 15,250 | $22.40 | 19,500(D) | View → |
| Apr 14, 2026 | Apr 16 1:47 AM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 37,500 | $19.08 | 20,000(D) | View → |
| Apr 6, 2026 | Apr 7 10:17 PM | Roy D. BaynesDirector | Option Exercise | 10,000 | $26.52 | 0(D) | View → |
| Apr 1, 2026 | Apr 2 9:55 PM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 60,000 | $15.46 | 0(D) | View → |
| Apr 1, 2026 | Apr 2 9:55 PM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 10,000 | $15.46 | 45,000(D) | View → |
| Mar 16, 2026 | Mar 18 8:05 PM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 10,000 | $19.08 | 10,000(D) | View → |
| Feb 20, 2026 | Feb 24 9:05 PM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 60,000 | $15.46 | 60,000(D) | View → |
| Feb 17, 2026 | Feb 19 9:10 PM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 10,000 | $19.08 | 20,000(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Grant/Award | 303,600 | $33.10 | 303,600(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Jula InrigCHIEF MEDICAL OFFICER | Grant/Award | 75,000 | $33.10 | 75,000(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Grant/Award | 75,000 | $33.10 | 75,000(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Peter HeermaCHIEF COMMERCIAL OFFICER | Grant/Award | 69,640 | $33.10 | 69,640(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | William E. RoteChief Research Officer | Grant/Award | 53,570 | $33.10 | 53,570(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Sandra CalvinSVP, CHIEF ACCOUNTING OFFICER | Grant/Award | 20,160 | $33.10 | 20,160(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Elizabeth E ReedChief Legal Officer and GC | Grant/Award | 66,960 | $33.10 | 66,960(D) | View → |
| Jan 27, 2026 | Jan 28 1:25 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 51,865 | $15.46 | 120,000(D) | View → |
| Jan 23, 2026 | Jan 28 1:25 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 8,135 | $15.46 | 171,865(D) | View → |